References
1. Talcott KE, Garg RJ, Garg SJ. Ophthalmic manifestations of leukemia.
Current Opinion in Ophthalmology. 2016;27(6):545–51.
2. Yassin MA, Ata F, Mohamed SF, Alkhateeb A, Naeem U, Al-Qatami AI, et
al. Ophthalmologic manifestations as the initial presentation of chronic
myeloid leukemia: A Review. Survey of Ophthalmology. 2022;67(2):530–43.
3. Awuah A, Asiedu K, Adanusa M, Ntodie M, Acquah E, Kyei S. A case of
leukemic retinopathy mimicking common ischemic retinopathies. Clinical
Case Reports. 2015;4(2):133–7.
4. Goel N, Pangtey B, Thakar M, Raina UK, Ghosh B. Chronic myeloid
leukemia presenting with bilateral central retinal vein occlusion and
massive retinal infiltrates. Journal of American Association for
Pediatric Ophthalmology and Strabismus. 2012;16(4):406–8.
5. Porcu P, Danielson CF, Orazi A, Heerema NA, Gabig TG, McCarthy LJ.
Therapeutic leukapheresis in hyperleucocytic leukaemias: Lack of
correlation between degree of cytoreduction and early mortality rate.
British Journal of Haematology. 1997;98(2):433–6.
6. Almeida DRP, Chin EK, Grant LW. Chronic myelogenous leukemia
presenting with bilateral optic disc neovascularization. Canadian
Journal of Ophthalmology. 2014;49(3).
7. Bewersdorf, J. P., Giri, S., Tallman, M. S., Zeidan, A. M., & Stahl,
M. (2020). Leukapheresis for the management of hyperleukocytosis in
acute myeloid leukemia—a systematic review and meta‐analysis.
Transfusion, 60(10), 2360–2369. https://doi.org/10.1111/trf.15994
8. Stahl M, Shallis RM, Wei W, Montesinos P, Lengline E, Neukirchen J,
et al. Management of hyperleukocytosis and impact of leukapheresis among
patients with Acute myeloid leukemia (AML) on short- and long-term
clinical outcomes: A large, retrospective, Multicenter, International
Study. Leukemia. 2020;34(12):3149–60.
9. Pastore F, Pastore A, Wittmann G, Hiddemann W, Spiekermann K. The
role of Therapeutic Leukapheresis in hyperleukocytotic AML. PLoS ONE.
2014;9(4).
10. Godbey EA, Dalton JB, Lai G, Sanford KW, Roseff SD. First reported
case of leukocytapheresis in Plasma Cell Leukemia. Transfusion.
2019;60(1):11–2.
11. Mohamed, M., Oakley, C., McEwen, F., & Connelley, G. (2015).
Leucapheresis for management of retinopathy in chronic myeloid
leukaemia. BMJ case reports, 2015, bcr2015212889.
https://doi.org/10.1136/bcr-2015-212889
12. Padmanabhan A, Connelly‐Smith L, Aqui N, Balogun RA, Klingel R,
Meyer E, et al. Guidelines on the use of therapeutic apheresis in
clinical practice – evidence‐based approach from the Writing Committee
of the American Society for Apheresis: The eighth special issue. Journal
of Clinical Apheresis. 2019;34(3):171–354.